When an employer purchases a health insurance plan for their employees, they can opt in or opt out of the coverage of medications for the treatment of obesity, explains Sarah Stombaugh, MD, an obesity medicine physician
Strong GH release, strong appetite stimulation, moderate cortisol and prolactin elevation
Radial and vertical extension is common at the time of diagnosis
Sleep and memory consolidation dysfunction in psychiatric disorders: evidence for the involvement of extracellular matrix molecules
MGB said it will continue to cover Wegovy, a rival GLP-1 from Novo Nordisk, and three other obesity drugs
Speak with your doctor if you experience common side effects like loose stools or cramping in your abdomen